Targeting Glial Cells

This video discusses the role of glial cells in chronic pain and their interaction with neuromodulation. It explains how glial cells, which make up 90% of neural cells, contribute to pain maintenance through neuroinflammation. The speaker highlights the Differential Targeted Multiplex (DTM) approach, which engages both neurons and glial cells for superior pain relief compared to traditional spinal cord stimulation (SCS). Multiple randomized controlled trials show significantly higher pain reduction rates using DTM. The presentation underscores the need for a scientific, mechanism-driven approach to neuromodulation for optimizing patient outcomes.